TGTX

NASDAQ · Biotechnology

Tg Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$58.11

+0.95 (+1.66%)

As of Sep 22, 9:53 PM ET ·

TGTX News1 articles

TG Therapeutics Stock Drops 9.8% Despite Strong BRIUMVI Sales as Costs Surge

TG Therapeutics shares fell 9.8% as Q2 revenue rose 70% but operating income declined 38% on surging costs. Guidance raised modestly.